A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain.

Pornnoppadol, Ghasidit; Zhang, Boya; Desai, Alec A; Berardi, Anthony; Remmer, Henriette A; Tessier, Peter M; Greineder, Colin F

Pornnoppadol, Ghasidit; Zhang, Boya; Desai, Alec A; Berardi, Anthony; Remmer, Henriette A; Tessier, Peter M; Greineder, Colin F.

Affiliation

Pornnoppadol G; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan, United States of America.
Zhang B; BioInterfaces Institute, University of Michigan, Ann Arbor, Michigan, United States of America.
Desai AA; BioInterfaces Institute, University of Michigan, Ann Arbor, Michigan, United States of America.
Berardi A; Department of Pharmacology, University of Michigan, Ann Arbor, Michigan, United States of America.
Remmer HA; BioInterfaces Institute, University of Michigan, Ann Arbor, Michigan, United States of America.
Tessier PM; Department of Chemical Engineering, University of Michigan, Ann Arbor, Michigan, United States of America.
Greineder CF; BioInterfaces Institute, University of Michigan, Ann Arbor, Michigan, United States of America.

PLoS One ; 16(10): e0252558, 2021.

Article in En | MEDLINE | ID: mdl-34634047

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Light Chains / Hybridomas / Antibodies, Monoclonal / Multiple Myeloma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google